scholarly journals Control of Benzimidazole- and DMI-Resistant Strains of Cercospora beticola with Strobilurin Fungicides

Plant Disease ◽  
2006 ◽  
Vol 90 (4) ◽  
pp. 419-424 ◽  
Author(s):  
G. S. Karaoglanidis ◽  
G. Bardas
Keyword(s):  
Resistant Isolate ◽  
Cercospora Beticola ◽  
Control Efficacy ◽  
Benzimidazole Fungicides ◽  
High Frequencies ◽  
Strobilurin Fungicides ◽  
Evolution Of Resistance ◽  
Dmi Fungicides ◽  
Strobilurin Fungicide ◽  
Resistant Strains

The control efficacy of two new strobilurin fungicides, trifloxystrobin and pyraclostrobin, against Cercospora beticola isolates resistant and sensitive to sterol demethylation-inhibiting (DMI) fungicides and benzimidazole fungicides and the effects on evolution of resistance were tested in the current study. Control efficacy of strobilurin fungicides was measured using three C. beticola isolates, one DMI-resistant (DMIR), one benzimidazole-resistant (BENR), and one of wild-type sensitivity (WCB). Both pyraclostrobin and trifloxystrobin provided satisfactory control of all the three isolates used in the study, when applied at 5 μg ml-1 and very high levels of control when applied at 10 μg ml-1. Control was independent of the isolate sensitivity to benomyl and difenoconazole. In contrast, benomyl applied at 10 μg ml-1 failed to control sufficiently the benzimidazole-resistant isolate, whereas difenoconazole applied at either 5 or 10 μg ml-1 failed to provide satisfactory control of the DMI-resistant isolate of the pathogen. The effects of strobilurin fungicide applications on the evolution of resistance to benzimidazole and DMI fungicides were tested under field conditions in a 2-year experiment (2003 to 2004). Applications of either trifloxystrobin or pyraclostrobin provided high levels of disease control during both years of the study, whereas applications of either benomyl or difenoconazole provided a moderate control efficacy. Measurements of resistance frequencies to benomyl and to difenoconazole showed that successive applications of benomyl tended to select for high frequencies of benzimidazole-resistant phenotypes, whereas successive applications of difenoconazole tended to select for high frequencies of DMI-resistant phenotypes. In contrast, applications of either trifloxystrobin or pyraclostrobin prevented an increase of benzimidazole- or DMI-resistant phenotypes compared with the plots treated with benomyl or difenoconazole, respectively, and decreased frequency of resistance compared with untreated control plots.

scholarly journals Comparative Efficacy, Selection of Effective Partners, and Application Time of Strobilurin Fungicides for Control of Cercospora Leaf Spot of Sugar Beet

Plant Disease ◽  
2006 ◽  
Vol 90 (6) ◽  
pp. 820-825 ◽  
Author(s):  
D. A. Karadimos ◽  
G. S. Karaoglanidis
Keyword(s):  
Mixture Component ◽  
Systemic Fungicide ◽  
Comparative Efficacy ◽  
Cercospora Leaf Spot ◽  
Control Efficacy ◽  
Strobilurin Fungicides ◽  
Calculated Ratio ◽  
Fungicide Mixtures ◽  
Strobilurin Fungicide ◽  
Selection Of

In this study, we attempt to optimize the use of strobilurin fungicides by testing the efficacy of azoxystrobin, kresoxim-methyl, pyraclostrobin, and trifloxystrobin under field conditions, by testing for the most efficient partners in fungicide mixtures, and by testing control efficacy of strobilurin fungicides applied at several application times to determine the better options for disease management. Results showed that trifloxystrobin was the most efficient strobilurin fungicide, followed by pyraclostrobin. Azoxystrobin provided a modest to poor control efficacy, whereas kresoxim-methyl provided only poor disease control efficacy. Mixtures of azoxystrobin and trifloxystrobin with either chlorothalonil or maneb and difenoconazole or flutriafol were tested for their efficacy in controlling the disease. The results showed that the azoxystrobin-containing mixtures provided significantly better control compared with that obtained by single applications of each mixture component. The mixtures of trifloxystrobin with maneb or with difenoconazole or flutriafol provided control efficacy similar to that obtained by single applications of trifloxystrobin, whereas the mixture of trifloxystrobin and chlorothalonil provided significantly lower control efficacy compared with the other trifloxystrobin-containing mixtures tested. For both strobilurin fungicides tested, the calculated ratio between the observed and the expected control efficacy ranged around the value of 1, suggesting additive interactions between the mixtures' components. To determine the most appropriate time for strobilurin fungicides application, trifloxystrobin was applied as the first two, the middle two, or the final two consecutive treatments of six fungicide applications. The remaining fungicide treatments in the spray schedules were carried out by applying the systemic fungicide difenoconazole. Results showed that a higher control efficacy was obtained when trifloxystrobin was applied in either of the earlier applications.

scholarly journals A Retrospective Study on Amoxicillin Susceptibility in Severe Haemophilus influenzae Pneumonia

2020 ◽  
Vol 2020 ◽  
pp. 1-7
Author(s):  
Pierre Danneels ◽  
Maria Concetta Postorino ◽  
Alessio Strazzulla ◽  
Nabil Belfeki ◽  
Aurelia Pitch ◽  
...  
Keyword(s):  
Risk Factors ◽  
Haemophilus Influenzae ◽  
Severe Pneumonia ◽  
Chronic Obstructive ◽  
Ventilator Associated Pneumonia ◽  
Obstructive Pulmonary Disease ◽  
Amoxicillin Clavulanic Acid ◽  
Evolution Of Resistance ◽  
Resistant Strains ◽  
Over Time

Introduction. Treatment of Haemophilus influenzae (Hi) pneumonia is on concern because resistance to amoxicillin is largely diffused. This study describes the evolution of resistance to amoxicillin and amoxicillin/clavulanic acid (AMC) in Hi isolates and characteristics of patients with Hi severe pneumonia. Methods. A monocentric retrospective observational study including patients from 2008 to 2017 with severe pneumonia hospitalized in ICU. Evolution of amoxicillin and AMC susceptibility was showed. Characteristics of patients with Hi pneumonia were compared to characteristics of patients with Streptococcus pneumoniae (Sp) pneumonia, as reference. Risk factors for amoxicillin resistance in Hi were investigated. Results. Overall, 113 patients with Hi and 132 with Sp pneumonia were included. The percentages of AMC resistance among Hi strains decreased over the years (from 10% in 2008-2009 to 0% in 2016-2017) while resistance to amoxicillin remained stable at 20%. Also, percentages of Sp resistant strains for amoxicillin decreased over years (from 25% to 3%). Patients with Hi pneumonia experienced higher prevalence of bronchitis (18% vs. 8%, p=0.02, chronic obstructive pulmonary disease (43% vs. 30% p=0.03), HAP (18% vs. 7%, p=0.01, ventilator-associated pneumonia (27% vs. 17%, p=0.04, and longer duration of mechanical ventilation (8 days vs. 6 days, p=0.04) than patients with Sp pneumonia. Patients with Sp pneumonia had more frequently local complications than patients with Hi pneumonia (17% vs. 7%, p=0.03). De-escalation of antibiotics was more frequent in patients with Sp than in patients with Hi (67% vs. 53%, p=0.03). No risk factors were associated with amoxicillin resistance among patients with Hi pneumonia. Conclusions. Amoxicillin resistance was stable over time, but no risk factors were detected. AMC resistance was extremely low, suggesting that AMC could be used for empiric treatment of Hi pneumonia, as well as other molecules, namely, cephalosporins. Patients with Hi pneumonia had more pulmonary comorbidities and severe diseases than patients with Sp pneumonia.

scholarly journals Antimicrobial Resistance of 1,113Streptococcus pneumoniae Isolates from Patients with Respiratory Tract Infections in Spain: Results of a 1-Year (1996–1997) Multicenter Surveillance Study

1999 ◽  
Vol 43 (2) ◽  
pp. 357-359 ◽  
Author(s):  
Fernando Baquero ◽  
José Angel García-Rodríguez ◽  
Juan García de Lomas ◽  
Lorenzo Aguilar ◽  
Keyword(s):  
Streptococcus Pneumoniae ◽  
Antimicrobial Resistance ◽  
Respiratory Tract ◽  
Middle Ear ◽  
Respiratory Tract Infections ◽  
Surveillance Study ◽  
High Frequencies ◽  
Resistant Strains ◽  
Tract Infections

A nationwide susceptibility surveillance of 1,113Streptococcus pneumoniae isolates was carried out and found the following percentages of resistance: cefuroxime, 46%; penicillin, 37%; macrolides, 33%; aminopenicillins, 24%; cefotaxime, 13%; and ceftriaxone, 8%. A significant (P < 0.05) seasonality pattern for β-lactam antibiotics was observed. Resistance to macrolides was higher (P < 0.05) in middle-ear samples. Higher percentages of resistance to cefuroxime and macrolides were observed among penicillin-intermediate and -resistant strains, whereas high frequencies of resistance to aminopenicillins and expanded-spectrum cephalosporins were observed only among penicillin-resistant strains.

scholarly journals Molecular Epidemiology of Antimicrobial-Resistant Commensal Escherichia coli Strains in a Cohort of Newborn Calves

2005 ◽  
Vol 71 (11) ◽  
pp. 6680-6688 ◽  
Author(s):  
Deborah V. Hoyle ◽  
Catherine M. Yates ◽  
Margo E. Chase-Topping ◽  
Esther J. Turner ◽  
Sarah E. Davies ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Turning Point ◽  
Temporal Trends ◽  
Resistant Isolate ◽  
Phenotypic Characterization ◽  
Environmental Source ◽  
Newborn Calves ◽  
Resistant Strains ◽  
Multiple Strains ◽  
Common Combination

ABSTRACT Pulsed-field gel electrophoresis (PFGE) was used to investigate the dissemination and diversity of ampicillin-resistant (Ampr) and nalidixic acid-resistant (Nalr) commensal Escherichia coli strains in a cohort of 48 newborn calves. Calves were sampled weekly from birth for up to 21 weeks and a single resistant isolate selected from positive samples for genotyping and further phenotypic characterization. The Ampr population showed the greatest diversity, with a total of 56 different genotype patterns identified, of which 5 predominated, while the Nalr population appeared to be largely clonal, with over 97% of isolates belonging to just two different PFGE patterns. Distinct temporal trends were identified in the distribution of several Ampr genotypes across the cohort, with certain patterns predominating at different points in the study. Cumulative recognition of new Ampr genotypes within the cohort was biphasic, with a turning point coinciding with the housing of the cohort midway through the study, suggesting that colonizing strains were from an environmental source on the farm. Multiply resistant isolates dominated the collection, with >95% of isolates showing resistance to at least two additional antimicrobials. Carriage of resistance to streptomycin, sulfamethoxazole, and tetracycline was the most common combination, found across several different genotypes, suggesting the possible spread of a common resistance element across multiple strains. The proportion of Ampr isolates carrying sulfamethoxazole resistance increased significantly over the study period (P < 0.05), coinciding with a decline in the most common genotype pattern. These data indicate that calves were colonized by a succession of multiply resistant strains, with a probable environmental source, that disseminated through the cohort over time.

scholarly journals Efficacy of Variable Tetraconazole Rates Against Cercospora beticola Isolates with Differing In Vitro Sensitivities to DMI Fungicides

Plant Disease ◽  
2012 ◽  
Vol 96 (12) ◽  
pp. 1749-1756 ◽  
Author(s):  
Melvin D. Bolton ◽  
Viviana Rivera-Varas ◽  
Luis E. del Río Mendoza ◽  
Mohamed F. R. Khan ◽  
Gary A. Secor
Keyword(s):  
Sugar Beet ◽  
Disease Severity ◽  
Cercospora Beticola ◽  
In Planta ◽  
Sensitivity Testing ◽  
In Vitro Sensitivity ◽  
Wide Range ◽  
Fungicide Efficacy ◽  
Dmi Fungicides

Cercospora leaf spot (CLS) of sugar beet is caused by the fungus Cercospora beticola. CLS management practices include the application of the sterol demethylation inhibitor (DMI) fungicides tetraconazole, difenoconazole, and prothioconazole. Evaluating resistance to DMIs is a major focus for CLS fungicide resistance management. Isolates were collected in 1997 and 1998 (baseline sensitivity to tetraconazole, prothioconazole, or difenoconazole) and 2007 through 2010 from the major sugar-beet-growing regions of Minnesota and North Dakota and assessed for in vitro sensitivity to two or three DMI fungicides. Most (47%) isolates collected in 1997–98 exhibited 50% effective concentration (EC50) values for tetraconazole of <0.01 μg ml–1, whereas no isolates could be found in this EC50 range in 2010. Since 2007, annual median and mean tetraconazole EC50 values have generally been increasing, and the frequency of isolates with EC50 values >0.11 μg ml–1 increased from 2008 to 2010. In contrast, the frequency of isolates with EC50 values for prothioconazole of >1.0 μg ml–1 has been decreasing since 2007. Annual median difenoconazole EC50 values appears to be stable, although annual mean EC50 values generally have been increasing for this fungicide. Although EC50 values are important for gauging fungicide sensitivity trends, a rigorous comparison of the relationship between in vitro EC50 values and loss of fungicide efficacy in planta has not been conducted for C. beticola. To explore this, 12 isolates exhibiting a wide range of tetraconazole EC50 values were inoculated to sugar beet but no tetraconazole was applied. No relationship was found between isolate EC50 value and disease severity. To assess whether EC50 values are related to fungicide efficacy in planta, sugar beet plants were sprayed with various dilutions of Eminent, the commercial formulation of tetraconazole, and subsequently inoculated with isolates that exhibited very low, medium, or high tetraconazole EC50 values. The high EC50 isolate caused significantly more disease than isolates with medium or very low EC50 values at the field application rate and most reduced rates. Because in vitro sensitivity testing is typically carried out with the active ingredient of the commercial fungicide, we investigated whether loss of disease control was the same for tetraconazole as for the commercial product Eminent. The high EC50 isolate caused more disease on plants treated with tetraconazole than Eminent but disease severity was not different between plants inoculated with the very low EC50 isolate.

scholarly journals 621. In vitro Ceftazidime: Avibactam Resistance in Carbapenem-Resistant Enterobacteriaceae Isolates

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S288-S289
Author(s):  
Maymonah Belal ◽  
Lori Villasis ◽  
Elizabeth Diago-Navarro ◽  
Michael Motley ◽  
Allen Young; Eric Spitzer ◽  
...  
Keyword(s):  
Resistant Isolate ◽  
Ventilator Associated Pneumonia ◽  
Repeated Testing ◽  
Klebsiella Species ◽  
Carbapenem Resistant ◽  
Strain Collection ◽  
Enterobacter Species ◽  
Resistant Strains ◽  
Carbapenem Resistant Enterobacteriaceae

Abstract Background Ceftazidime–avibactam (CAZ-AVI) is a new antibiotic with activity against many Carbapenem-resistant Enterobacteriaceae (CRE). Although CAZ-AVI resistance in CRE has been reported, it is not consistently assessed. Our study aimed to assess the prevalence of CAZ-AVI resistance in CRE isolated from patients with and without prior exposure to CAZ-AVI. Methods We tested 116 CRE isolates for CAZ-AVI resistance by Kirby–Bauer (KB) disk diffusion susceptibility. Resistant isolates were verified by repeat KB and E-test performed by the Stony Brook Hospital laboratory. The blaKPC gene of resistant strains was amplified by PCR and sequenced. Patient data were used to determine whether patients were colonized or infected, and whether they were exposed to CAZ-AVI. Results Of the 116 CRE isolates from 86 patients (96 encounters), 50% were Klebsiella species, 23.2% were Enterobacter species, 10.3% Escherichia coli and 16.5% other CRE. They were recovered from colonized (37%) and infected (63%) patients of which 18% were treated with CAZ-AVI during their hospitalizations (median duration of therapy, 6 days). Two CRE isolates (1.7%) were found to be resistant on repeated testing. One isolate was K. pneumoniae derived from the sputum of a patient diagnosed with ventilator-associated pneumonia who received 40 days of CAZ-AVI therapy prior to isolation of the resistant isolate (KB diameter 20 mm, MIC > 512 μg/mL by E-Test). Sequencing of the strain’s blaKPC3 gene revealed a previously described Ambler-position D179Y mutation that has been shown to convey resistance. The second CAZ-AVI-resistant K. pneumoniae (KB diameter 19 mm, MIC 64 μg/mL by E-test) was isolated from the urine of a colonized patient naïve to CAZ-AVI therapy. The strain’s blaKPC10 gene had no mutations. Conclusion In our strain collection, the rate of resistance to CAZ-AVI remains low <2%. Although we found one mutation (D179Y) previously linked to CAZ-AVI resistance we also discovered one K. pneumoniae isolate with in vitro resistance to CAZ-AVI that did not exhibit any blaKPC mutations conveying CAZ-AVI resistance. Interestingly, this strain was derived from a patient with no prior CAZ-AVI exposure. Whole-genome sequencing will be performed to identify other genes or mutations that may confer resistance. Disclosures All authors: No reported disclosures.

scholarly journals Multiplecyp51A-Based Mechanisms Identified in Azole-Resistant Isolates of Aspergillus fumigatus from China

2015 ◽  
Vol 59 (7) ◽  
pp. 4321-4325 ◽  
Author(s):  
Musang Liu ◽  
Rong Zeng ◽  
Lili Zhang ◽  
Dongmei Li ◽  
Guixia Lv ◽  
...  
Keyword(s):  
Aspergillus Fumigatus ◽  
Clinical Isolates ◽  
Resistant Isolate ◽  
Azole Resistance ◽  
Content Type ◽  
Resistant Strains

ABSTRACTSeventy-twoA. fumigatusclinical isolates from China were investigated for azole resistance based on mutations ofcyp51A. We identified four azole-resistant strains, among which we found three strains highly resistant to itraconazole, two of which exhibit the TR34/L98H/S297T/F495I mutation, while one carries only the TR34/L98H mutation. To our knowledge, the latter has not been found previously in China. The fourth multiazole-resistant isolate (with only moderate itraconazole resistance) carries a new G432A mutation.

scholarly journals Sensitivity of Colletotrichum Species, Including C. fioriniae and C. nymphaeae, from Peach to Demethylation Inhibitor Fungicides

Plant Disease ◽  
2016 ◽  
Vol 100 (12) ◽  
pp. 2434-2441 ◽  
Author(s):  
S. N. Chen ◽  
C. X. Luo ◽  
M. J. Hu ◽  
G. Schnabel
Keyword(s):  
South Carolina ◽  
Colletotrichum Acutatum ◽  
In Vitro Activity ◽  
Internal Transcribed Spacer Region ◽  
Control Efficacy ◽  
Dmi Fungicides ◽  
Colletotrichum Spp ◽  
Colletotrichum Acutatum Species Complex ◽  
Demethylation Inhibitor

Few fungicides are effective against anthracnose, caused by Colletotrichum spp., and emerging resistance makes the search for chemical alternatives more relevant. Isolates of the Colletotrichum acutatum species complex were collected from South Carolina and Georgia peach orchards and phylogenetic analysis of the combined internal transcribed spacer region, glyceraldehyde-3-phosphate dehydrogenase, and β-tubulin gene sequences separated the isolates into C. nymphaeae and C. fioriniae. The sensitivity of these and three other previously reported Colletotrichum spp. from peach, including C. fructicola, C. siamense, and C. truncatum, to demethylation inhibitor (DMI) fungicides difenoconazole, propiconazole, tebuconazole, metconazole, flutriafol, and fenbuconazole was determined based upon mycelial growth inhibition. C. truncatum was resistant to tebuconazole, metconazole, flutriafol, and fenbuconazole and C. nymphaeae was resistant to flutriafol and fenbuconazole based on 50% effective concentration (EC50) values >100 μg/ml. C. fructicola and C. siamense were sensitive to all DMI fungicides (EC50 values of 0.2 to 13.1 μg/ml). C. fioriniae subgroup 2 isolates were less sensitive to DMI fungicides (EC50 values of 0.5 to 16.2 μg/ml) compared with C. fioriniae subgroup 1 (EC50 values of 0.03 to 2.1 μg/ml). Difenoconazole and propiconazole provided the best control efficacy in vitro to all five species, with EC50 values of 0.2 to 2.7 μg/ml. Tebuconazole and metconazole were effective against all Colletotrichum spp., except for C. truncatum. The strong in vitro activity of some DMI fungicides against Colletotrichum spp. may be exploited for improved anthracnose disease management of peach.

scholarly journals Development of fluoroquinolone resistance in Enterococcus faecalis and role of mutations in the DNA gyrase gyrA gene.

1996 ◽  
Vol 40 (11) ◽  
pp. 2558-2561 ◽  
Author(s):  
J Tankovic ◽  
F Mahjoubi ◽  
P Courvalin ◽  
J Duval ◽  
R Leclerco
Keyword(s):  
Enterococcus Faecalis ◽  
Resistant Isolate ◽  
Fluoroquinolone Resistance ◽  
Gyra Gene ◽  
Single Clone ◽  
Total Dna ◽  
Resistant Strains ◽  
French Hospital ◽  
High Level

We have analyzed the development of fluoroquinolone resistance between 1986 and 1993 among clinical isolates of Enterococcus faecalis from a French hospital. One hundred randomly selected isolates per year were screened for resistance to ciprofloxacin (MIC > 2 micrograms/ml) and for high-level resistance to gentamicin (MIC > 1,000 micrograms/ml). The percentages of ciprofloxacin-resistant strains for these years were as follows: 1986, 0; 1987, 1; 1988 to 1989, 2; 1990, 6; 1991, 16; 1992, 24; and 1993, 14. Eighty-three percent of the ciprofloxacin-resistant isolates were coresistant to high levels of gentamicin. Forty-eight high-level gentamicin-resistant E. faecalis strains, which were resistant (24 strains) or susceptible (24 strains) to ciprofloxacin, were examined by pulsed-field gel electrophoresis (PFGE) of SmaI-digested total DNA. Numerous PFGE types were observed among the ciprofloxacin-susceptible isolates, whereas one type was largely predominant among the ciprofloxacin-resistant strains, which suggests that the increase in fluoroquinolone resistance was due to the spread of a single clone. A 241-bp fragment of gyrA, corresponding to the quinolone resistance-determining region, was amplified and sequenced for seven ciprofloxacin-resistant isolates. Six strains had high levels of resistance (MICs, 32 to 64 micrograms/ml) and had a mutation at position 83 (Escherichia coli coordinates) from Ser to Arg (three strains) or to Ile (two strains) or at position 87 from Glu to Gly (one strain), whereas the low-level-resistant isolate (MIC, 8 micrograms/ml) had no mutations.

scholarly journals Stochastic bacterial population dynamics restrict the establishment of antibiotic resistance from single cells

2020 ◽  
Vol 117 (32) ◽  
pp. 19455-19464 ◽  
Author(s):  
Helen K. Alexander ◽  
R. Craig MacLean
Keyword(s):  
De Novo ◽  
Single Cells ◽  
Treatment Strategies ◽  
Bacterial Populations ◽  
Resistance Plasmids ◽  
Evolution Of Resistance ◽  
Resistant Strains ◽  
Low Probability ◽  
Emergence Of Resistance ◽  
Resistant Cells

A better understanding of how antibiotic exposure impacts the evolution of resistance in bacterial populations is crucial for designing more sustainable treatment strategies. The conventional approach to this question is to measure the range of concentrations over which resistant strain(s) are selectively favored over a sensitive strain. Here, we instead investigate how antibiotic concentration impacts the initial establishment of resistance from single cells, mimicking the clonal expansion of a resistant lineage following mutation or horizontal gene transfer. Using twoPseudomonas aeruginosastrains carrying resistance plasmids, we show that single resistant cells have <5% probability of detectable outgrowth at antibiotic concentrations as low as one-eighth of the resistant strain’s minimum inhibitory concentration (MIC). This low probability of establishment is due to detrimental effects of antibiotics on resistant cells, coupled with the inherently stochastic nature of cell division and death on the single-cell level, which leads to loss of many nascent resistant lineages. Our findings suggest that moderate doses of antibiotics, well below the MIC of resistant strains, may effectively restrict de novo emergence of resistance even though they cannot clear already-large resistant populations.

Sign in / Sign up

Export Citation Format

Share Document